Synthszr Charts — die großen AI-Marken im Wettkampf ums Podium

Oracle Health

Oracle · 2× · tolest 21. Aug. 2026

Momentum

Oracle Health Clinical AI Agent is an AI-powered clinical assistant integrated into the Oracle Health EHR (Millennium platform) that supports physicians with documentation, coding, and chart review. In August 2026, new features for automated Professional Fee Coding, clinician-controlled real-time dictation, and AI-powered Chart Review were launched in the US. The system is based on a multi-agent architecture with semantic Reasoning that enables various AI agents to collaborate, understand clinical significance, and automate workflows while keeping control with the clinician. According to Oracle, the note-generation feature alone has already saved over 400,000 hours across US healthcare organizations.

Momentum-Verloop

04.07.02.10.

Features

Compliance/Certification	Listed on NHS England's registry of approved Ambient Voice Technology (AVT) suppliers meeting NHS standards
Deployment Model	Cloud-based on Oracle Cloud Infrastructure (OCI), available as a standalone feature that can work with any EHR
Use Case Scope	Ambulatory, inpatient and emergency department care, more than 30 medical specialty areas (e.g. cardiology, nephrology, urology, behavioral health)
Integrations	Directly integrated with Oracle Health EHR/Millennium platform; multi-agent system for order creation, coding, dictation and chart review
Platform	Based on the Oracle Digital Assistant platform, integrated into Oracle Health EHR (Millennium), runs on Oracle Cloud Infrastructure (OCI)
Price	Not publicly listed; custom quote per healthcare organization
Release Date	October 29, 2024 (2nd generation); new coding/dictation/chart review features: August 19, 2026 (U.S.)

Mehr Produkten in disse Kategorie: KI in't Gesundheitswesen

Belege (2)

Company Analysis: Oracle

As of 30/09/2026

HOLDSynthszr Vote

Data supports strong operating momentum (Q1 FY2027 revenue +30% YoY; OCI +121% YoY; RPO $664B) and management guidance implies continued high growth into Q2 FY2027. However, the investment/commitment profile is unusually heavy for a mature software company: FY2026 free cash flow was negative (-$23.7B) and the Aug 31, 2026 10‑Q disclosed $288B of additional data-center lease commitments. With forward P/E ~17.8x, the risk/reward is balanced: upside depends on sustained execution and a credible path to improved cash conversion, while downside is driven by utilization/pricing and fixed-obligation leverage. A HOLD is warranted until there is clearer evidence of durable free-cash-flow inflection alongside continued OCI growth.

Summary

Oracle Corporation (ORCL) is a diversified enterprise software and cloud provider with three core profit engines: (1) Database and middleware (including high-margin support/maintenance), (2) Cloud applications (Fusion ERP/HCM, NetSuite, Cerner/health), and (3) Oracle Cloud Infrastructure (OCI) for compute, storage, networking, and database services. Its core competencies remain mission-critical data management, performance/security at scale, and deep enterprise relationships that support cross-sell from on‑prem software into cloud subscriptions. Market position has shifted materially in the last year toward hyperscale-style infrastructure growth. In fiscal Q1 2027 (quarter ended Aug 31, 2026), Oracle reported total revenue of $19.3B (+30% YoY) and OCI (IaaS) revenue of $7.4B (+121% YoY), indicating that OCI is now the primary growth driver. The company’s competitive advantages are (a) database differentiation (including autonomous/managed database offerings), (b) integrated stack economics for database-heavy workloads, and (c) unusually large contracted backlog: remaining performance obligations (RPO) reached $664B (+$209B YoY). Oracle disclosed that ~13% of RPO is expected to be recognized as revenue over the next 12 months, with the remainder extending over multiple years, providing visibility but also emphasizing long-duration execution requirements. Recent months’ key developments are dominated by (1) record FY2026 results (reported June 10, 2026) and (2) the Q1 FY2027 step-change in OCI growth and RPO (reported Sept 10, 2026). Management also guided for Q2 FY2027 total revenue growth of ~30–34% (constant currency) and total cloud revenue growth of ~64–70% (constant currency). Non‑GAAP EPS guidance for Q2 FY2027 was $1.83–$1.91 (constant currency). Financially, valuation is not “cheap” on absolute terms but has moderated versus prior peaks: Yahoo Finance shows forward P/E around ~17.8x as of late Aug 2026. The central near-term debate is cash conversion: Oracle’s FY2026 free cash flow was negative (company cited -$23.7B) due to heavy infrastructure investment to expand OCI capacity. The latest 10‑Q also highlights very large future lease commitments tied to data centers ($288B additional lease commitments as of Aug 31, 2026), which increases fixed obligations and sensitivity to utilization and pricing. Outlook (short- to medium-term) is primarily a function of OCI capacity delivery, conversion of RPO into recognized revenue, and whether margins/FCF inflect as build-out matures. The data supports strong demand and backlog; the key risk is that capital intensity and long-dated commitments can keep free cash flow pressured even as reported revenue accelerates.

Key Takeaways

OCI has become Oracle’s main growth vector: Q1 FY2027 OCI (IaaS) revenue was $7.4B, up 121% YoY, alongside total revenue of $19.3B (+30% YoY).
Backlog visibility is exceptional but long-dated: RPO was $664B (+$209B YoY); Oracle expects ~13% to convert to revenue within 12 months, with the remainder spread over multiple years.
Guidance implies sustained high growth: for Q2 FY2027, Oracle guided total revenue growth of ~30–34% (constant currency) and total cloud revenue growth of ~64–70% (constant currency).
Valuation has normalized versus earlier periods: forward P/E is ~17.8x (Yahoo Finance, late Aug 2026), meaning execution and cash conversion matter more than multiple expansion.
Capital intensity and fixed obligations are the key financial constraint: FY2026 free cash flow was negative (-$23.7B) due to OCI investment, and the Aug 31, 2026 10‑Q disclosed $288B of additional data-center-related lease commitments.

Action Ideas

BUY

For investors with tolerance for elevated capital intensity, Oracle’s data shows a rare combination of (a) hyperscale-like infrastructure growth (OCI +121% YoY to $7.4B in Q1 FY2027), (b) accelerating consolidated growth (+30% YoY revenue to $19.3B), and (c) unusually large contracted backlog (RPO $664B). With forward P/E ~17.8x, the stock is not priced like an early-stage hypergrowth name, so the upside case is primarily continued delivery against guidance and evidence that backlog converts without structurally impairing margins/FCF.

Horizon: 12 mo.

HOLD

For investors already positioned, the data supports staying invested while monitoring cash conversion. Oracle’s Q2 FY2027 guidance (30–34% total revenue growth; 64–70% cloud growth in constant currency) and the scale of RPO provide near-term revenue visibility. However, the investment phase is still dominant, and the market’s focus is likely to remain on capex/leases and the timing of a durable FCF inflection rather than on revenue alone.

Horizon: 6 mo.

SELL

For investors with low tolerance for balance-sheet and fixed-commitment risk, the disclosed scale of future data-center lease commitments ($288B) and the recent negative FCF profile can justify reducing exposure despite strong top-line momentum. This is a risk-management action: the data indicates Oracle is in a heavy build-out phase where reported growth can coexist with pressured cash generation and higher operating leverage to utilization.

Horizon: 3 mo.

Contrarian Insights

• The headline RPO figure ($664B) is often interpreted as near-term revenue certainty; Oracle’s 10‑Q indicates only ~13% is expected to be recognized as revenue over the next 12 months, meaning the backlog is long-duration and execution/capacity delivery over several years is the binding constraint.
• Consensus enthusiasm focuses on OCI growth (+121% YoY), but the more decision-relevant variable for equity value over the next year may be fixed obligations and cash conversion: FY2026 free cash flow was negative (-$23.7B) and the company disclosed $288B of additional data-center lease commitments, which can keep free cash flow constrained even if revenue growth remains strong.